Cns-Active Drugs has 7 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Mycophenilic Acid, Clomipramine Hydrochloride, Digoxin. Patients taking Cns-Active Drugs should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 7
- Major
- 1
- Moderate
- 6
Major (1)
- Cns-Active Drugs + Mycophenilic Acid— May decrease mycophenolic acid concentrations; concomitant use is not recommended.
Moderate (6)
- Cns-Active Drugs + Clomipramine Hydrochloride— Caution is advised when using clomipramine concomitantly with other CNS-active drugs due to primary CNS effects of clomi…
- Cns-Active Drugs + Digoxin— Decreases digoxin concentrations. Requires monitoring and dose adjustment.
- Cns-Active Drugs + Olanzapine— Reduces olanzapine Cmax and AUC by about 60%; may be useful for olanzapine overdose treatment.
- Cns-Active Drugs + Olanzapine And Fuoxetine— Caution advised with concomitant CNS-active drugs; consider lower initial doses and conservative titration.
- Cns-Active Drugs + Venlafaxine Hcl Er— Risk of concomitant use with CNS-active drugs has not been systematically evaluated. Caution advised when used together.
- Cns-Active Drugs + Venlafaxine Hydrochloride— Risk of concomitant use has not been systematically evaluated. Caution is advised.